Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03636243Completed
Trial (2 arms), sponsored by CHU Nîmes. Primary endpoint: Reactive Hyperemia Index at Month 3. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03636243.